Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model

Journal of Clinical Investigation

Volumn 102, Issue 7, 1998, Pages 1413-1420

  Allaire, Eric ^a   Forough, Reza ^b   Clowes, Monika ^c   Starcher, Barry ^d   Clowes, Alexander W ^c  

^a HENRI MONDOR HOSPITAL   (France)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Aneurysm; Matrix metalloproteinases; Pharmacology; TIMP 1; Xenograft

Indexed keywords

COMPLEMENTARY DNA; ELASTIN; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; ANIMAL CELL; ANIMAL MODEL; AORTA ANEURYSM; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; XENOGRAFT;

EID: 0032190478     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2909     Document Type: Article

References (54)

1. Baxter, B.T., G.S. McGee, V.P. Shively, I.A.S. Drummond, S.N. Dixit, M. Yamaushi, and W.H. Pearce. 1992. Elastin content, cross-links, and mRNA in normal and aneurysmal human aorta. J Vasc. Surg. 16:192-200.
2. MacSweeney, S.T., J.T. Powell, and R.M. Greenhalgh. 1994. Pathogenesis of abdominal aortic aneurysm. Br. J. Surg. 81:935-941.
3. Anidjar, S., and E. Kieffer. 1992. Pathogenesis of acquired aneurysms of the abdominal aorta. Ann. Vasc. Surg. 6:298-305.
4. Ernst, C.B. 1993. Abdominal aortic aneurysm. N. Engl. J. Med. 328:1167-1172.
5. Koch, A.E., G.K. Haines, R.J. Rizzo, J.A. Radosevich, R.M. Pope, P.G. Robinson, and W.H. Pearce. 1990. Human abdominal aortic aneurysms. Immunopathologic analysis suggesting an immune-mediated response. Am. J. Pathol. 137:1199-1213.
6. Brophy, C.M., J.M. Reilly, G.J. Smith, and M.D. Tilson. 1991. The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann. Vasc. Surg. 5:229-233.
7. Freestone, T., R.J. Turner, A. Coady, D.J. Higman, R.M. Greenhalgh, and J.T. Powell. 1995. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscl. Thromb. Vasc. Biol. 15:1145-1151.
8. Dobrin, P.B., W.H. Baker, and W.C. Gley. 1984. Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. Arch. Surg. 119:405-409.
9. Anidjar. S., J.L. Salzmann, D. Gentric, P. Lagneau, J.P. Camilleri, and J.B. Michel. 1990. Elastase-induced experimental aneurysm in rat. Circulation. 82:973-981.
10. Allaire, E., P. Bruneval, C. Mandet, J.P. Becquemin, and J.B. Michel. 1997. The immunogenicity of the arterial extracellular matrix in arterial xenografts. Surgery. 122:73-81.
11. Mesh, CL., B.T. Baxter, W.H. Pearce, R.L. Chisholm, G.S. McGee, and J.S. Yao. 1992. Collagen and elastin gene expression in aortic aneurysms. Surgery. 112:256-261.
12. Birkedal-Hansen, H., W.G.I. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4:197-250.
13. Murphy, G., M.I. Cockett, R.V. Ward, and A.J. Docherty. 1991. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277:277-279.
14. Katsuda, S., Y. Okada, K. Imai, and I. Nakanishi. 1994. Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin. Am. J. Pathol. 145:1208-1218.
15. Shipley. J.M., G.A.R. Doyle, C.J. Fliszar, Q.Z. Ye, L.L. Johnson, S.D. Shapiro, H.G. Welgus, and R.M. Senior. 1996. The structural basis for the elastinolytic activity of the 92-kDa and 72-kDa gelatinases. J. Biol. Chem. 8:4335-4341.
16. Mecham, R.P., T.J. Broekelmann, C.J. Fliszar, S.D. Shapiro, H.G. Welgus, and R.M. Senior. 1997. Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J. Biol. Chem. 272: 18071-18076.
17. Newman, K.M., J. Jean Claude, H. Li, and W.G. Ramey. 1994. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation. 90:11224-11227.
18. Pearce, W.H., I. Sweis, J.S. Yao, W.J. McCarthy, and A.E. Koch. 1992. Interleukin-1 beta and tumor necrosis factor-alpha release in normal and diseased human infrarenal aortas. J. Vasc. Surg. 16:784-789.
19. Sarén, P., H.G. Welgus, and P.T. Kovanen. 1996. Alpha and IL-1 beta selectively induce expression of 92-kDa gelatinase by human macrophages. J. Immunol. 157:4159-4165.
20. Thompson. R.W., D.R. Holmes, R.A. Mertens, S. Liao, M.D. Botney, R.P. Mecham, H.G. Welgus, and W.C. Parks. 1995. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest. 96:318-326.
21. McMillan, W.D., B.K. Patterson, R.R. Keen, V.P. Shively, M. Cipollone, and W.H. Pearce. 1995. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arteriosel. Thromb. Vasc. Biol. 15:1139-1144.
22. Vine, N., and J.T. Powell. 1991. Metalloproteinases in degenerative aortic disease. Clin. Science. 81:233-239.
23. Allaire, E., C. Guettier, P. Bruneval, D. Plissonnier, and J.B. Michel. 1994. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J. Vasc. Surg. 19:446-456.
24. Allaire. E., C. Mandet, P. Bruneval, S. Bensenane, J.P. Becquemin, and J.B. Michel. 1996. Cell and extracellular matrix rejection in arterial concordant and discordant xenografts in rat. Transplantation. 62:794-803.
25. Libby, P. 1995. Molecular bases of the acute coronary syndromes. Circulation. 91:2844-2850.
26. Forough, R., S.T. Nikkari, D. Hasenstab, H. Lea, and A.W. Clowes. 1995. Cloning and characterization of a cDNA encoding the baboon tissue inhibitor of metalloproteinase-1 (TIMP-1). Gene. 163:267-271.
27. Forough, R., N. Koyama, D. Hasenstab, H. Lea, M.M. Clowes, S.T. Nikkari, and A.W. Clowes. 1996. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ. Res. 79:812-820.
28. Miller, A.D., and G.J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. Biotechniques. 7:980-990.
29. Starcher, B., and M. Conrad. 1995. A role for neutrophil elastase in the progression of solar elastosis. Connect. Tissue. Res. 31:133-140.
30. Abramson, S.R., G.E. Conner, H. Nagase, I. Neuhaus, and J.F.J. Woessner. 1995. Characterization of rat uterine matrilysin and its cDNA. Relationship to human pump-1 and activation of procollagenases. J. Biol. Chem. 270: 16016-16022.
31. Dcan, D.D., J. Martel-Pelletier, J.-P. Pelletier, D.S. Howell, and J.F. Woessner. 1989. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84:678-685.
32. Allaire. E., D. Hasenstab, R.D. Kenagy, M.M. Clowes, and A.W. Clowes. 1997. Plasminogen activator inhibitor type-1 (PAI-1) overexpession by retrovirally transduced cell seeding prevents arterial aneurysm formation and rupture in rats. Circulation. 96:1-171. (Abstr.)
33. Carmeliet, P., L. Moons, R. Lijnen, M. Baes, V. Lemaître, P. Tipping, A. Drew, Y. Eeckhout, F. Lupu, and D. Collen. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17:439-144.
34. Camiolo, S.M., M.R. Siuta, and J.M. Madeja. 1982. Improved medium for extraction of plasminogen activator from tissue. Prep. Biochem. 12:297-305.
35. Clowes, A.W, M.M. Clowes, Y.P.T. Au, and M.A. Reidy. 1990. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ. Res. 67:61-67.
36. Bendeck, M.P., N. Zempo, A.W. Clowes, R.E. Galardy, and M.A. Reidy. 1994. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 75:539-545.
37. Zempo, N., R.D. Kenagy, Y.P. Au, M. Bendeck, M.M. Clowes, M.A. Reidy, and A.W. Clowes. 1994. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J. Vasc. Surg. 20:209-217.
38. Holmes, D.R., A. Lopez-Candales, S. Liao, and R.W. Thompson. 1996. Smooth muscle cell apoptosis and p53 expression in human abdominal aortic aneurysms. Ann. NY Acad. Sci. 800:286-287.
39. Tilson, M.D. 1995. Similarities of an autoantigen in aneurysmal disease of the human abdominal aorta to a 36-kDa microfibril-associated bovine aortic glycoprotein. Biochem. Biophys. Res. Com. 213:40-43.
40. Gregory, A.K., N.X. Yin, J. Capella, S. Xia, K.M. Newman, and M.D. Tilson. 1996. Features of autoimmunity in the abdominal aortic aneurysm. Ann. Surg. 131:85-88.
41. Feldman, M., F.M. Brennan, and R.N. Maini. 1996. Rhumatoid arthritis. Cell. 85:307-310.
42. Newman, K.M., Y. Ogata, A.M. Malon, E. Irizarry, R.H. Gandhi, and H. Nagase. 1994. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler. Thromb. 14: 1315-1320.
43. Newman, K.M., J. Jean Claude, H. Li, J.V. Scholes, Y. Ogata, H. Nagase, and M.D. Tilson. 1994. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J. Vasc. Surg. 20:814-820.
44. Petrinec, D., S. Liao, D.R. Holmes, J.M. Reilly, W.C. Parks, and R.W. Thompson. 1996. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J. Vasc. Surg. 23:336-346.
45. Sorsa, T., O. Lindy, Y.T. Konttinen, K. Suomalainen, T. Ingman, H. Saari, S. Halinen, H.S. Lee, L.M. Golub, J. Hall, and S. Simon. 1993. Doxycyclin in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob. Agents Chemother. 37:592-594.
46. Okada, Y., T. Morodomi, J.J. Enghild, K. Suzuki, A. Yasui, I. Nakanishi, G. Salvesen, and H. Nagase. 1990. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur. J. Biochem. 194:721-730.
47. Pei, D., and S.J. Weiss. 1996. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271:9135-9140.
48. Butler, G.S., H. Will, S.J. Atkinson, and G. Murphy. 1997. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur. J. Biochem. 244:653-657.
49. Corcoran, M.L., and W.G. Stetler Stevenson. 1995. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J. Biol. Chem. 270:13453-13459.
50. Chesler, L., D.W. Golde, N. Bersch, and M.D. Johnson. 1995. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood. 86:4506-4515.
51. Okada, Y., H. Nagase, and E.D.J. Harris. 1987. Matrix metalloproteinases 1,2, and 3 from rheumatoid synovial cells are sufficient to destroy joints. J. Rheumatol. 14:41-42.
52. Shapiro, S.D., D.K. Kobayashi, and T.J. Ley. 1993. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268:23824-23829.
53. Senior, R.M., G.L. Griffin, C.J. Fliszar, S.D. Shapiro, G.I. Goldberg, and H.G. Welgus. 1991. Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266:7870-7875.
54. Mecham, R.P., T.J. Broekelmann, C.J. Fliszar, S.D. Shapiro, H.G. Welgus, and R.M. Senior. 1997. Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J. Biol. Chem. 272: 18071-18076.